Detalhe da pesquisa
1.
Tolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, placebo-controlled, Phase 2 study comparing different dose-escalation schemes.
Diabetes Obes Metab
; 25(10): 2805-2814, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311722
2.
A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia.
J Clin Psychopharmacol
; 39(4): 318-328, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205187
3.
Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The STOP-PASC Randomized Clinical Trial.
JAMA Intern Med
; 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38848477